Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCLstudy: BVS vs OMT for Non-Culprit Lesions in STEMI
NCT02982057Phase 3Completed
- Start
- Jan 2015
- Primary completion
- Nov 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms). Primary endpoint: Measure size of the vulnerable plaque at 2 years. Started Jan 2015; status: completed.
Beyond the preview
Go deeper on NCT02982057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02982057.